首页> 外文期刊>European journal of clinical nutrition >Change in the fatty acid pattern of erythrocyte membrane phospholipids after oral supplementation of specific fatty acids in patients with gastrointestinal diseases.
【24h】

Change in the fatty acid pattern of erythrocyte membrane phospholipids after oral supplementation of specific fatty acids in patients with gastrointestinal diseases.

机译:胃肠道疾病患者口服补充特定脂肪酸后红细胞膜磷脂的脂肪酸模式变化。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/OBJECTIVES: The fatty acid pattern of membrane phospholipids is suggested to affect membrane fluidity and epithelial barrier function as a result of membrane fatty acid unsaturation. The incorporation of n-3 polyunsaturated fatty acids (PUFAs) into membrane phospholipids may diminish inflammatory potential in patients with gastrointestinal diseases. The aim of this study was to improve the fatty acid profile of erythrocyte membrane phospholipids after oral supplementation of specific fatty acids in patients with maldigestion and/or malabsorption. SUBJECTS/METHODS: We conducted a randomized, double-blind, controlled trial. A total of 48 patients with gastrointestinal diseases received either fat-soluble vitamins A,D,E,K (ADEK) or ADEK plus fatty acids alpha-linolenic acid (ALA), docosahexaenoic acid (DHA) and medium-chain triglycerides (FA-ADEK) for 12 weeks. The fatty acid profile of erythrocyte membrane phospholipids, dietary intake, plasma antioxidant vitamins and serum gamma-glutamyl transferase (GGT) were evaluated at baseline, 8 and 12 weeks after supplementation. RESULTS: Supplementation with FA-ADEK increased ALA, DHA and eicosapentaenoic acid (EPA) concentrations of erythrocyte membrane phospholipids by 0.040, 1.419 and 0.159%, respectively, compared with ADEK supplementation (-0.007, 0.151 and 0.002%, respectively) after 12 weeks (all P
机译:背景/目的:由于膜脂肪酸不饱和,建议膜磷脂的脂肪酸模式影响膜流动性和上皮屏障功能。将n-3多不饱和脂肪酸(PUFA)掺入膜磷脂可能会减少胃肠道疾病患者的炎症潜能。这项研究的目的是改善消化不良和/或吸收不良患者口服特定脂肪酸后改善红细胞膜磷脂的脂肪酸谱。受试者/方法:我们进行了一项随机,双盲,对照试验。共有48位胃肠道疾病患者接受脂溶性维生素A,D,E,K(ADEK)或ADEK以及脂肪酸α-亚麻酸(ALA),二十二碳六烯酸(DHA)和中链甘油三酸酯(FA- ADEK),持续12周。补充后第8、12周,在基线时评估红细胞膜磷脂的脂肪酸谱,饮食摄入,血浆抗氧化剂维生素和血清γ-谷氨酰转移酶(GGT)。结果:12周后,与添加ADEK相比,添加FA-ADEK可使红细胞膜磷脂的ALA,DHA和二十碳五烯酸(EPA)浓度分别增加0.040、1.419和0.159%,分别为-0.007、0.151和0.002% (所有P <或= 0.001)。与接受ADEK的患者相比,接受FA-ADEK的患者的血清GGT活性降低,8周后差异显着。结论:红细胞膜脂肪酸模式的显着变化表明消化不良和吸收不良患者口服n-3 PUFA。 ALA和DHA的增加以及ALA向EPA的转化分别归因于补充了足够量的ALA和DHA。血清GGT活性随氧化应激的降低而降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号